Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Pharmacogenetics|March 6, 2003
Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamsterDavid W Hein, Mark A Doll, Gong H Xiao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2008
Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic ratDavid W Hein, Jean Bendaly, Jason R Neale, et al.
Molecular Carcinogenesis|February 17, 2006
Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamsterDavid W Hein, Mark A Doll, Donald E Nerland, et al.
Alcoholism, Clinical and Experimental Research|November 15, 2013
S-adenosylhomocysteine inhibits NF-κB-mediated gene expression in hepatocytes and confers sensitivity to TNF cytotoxicityWalter H Watson, Tom J Burke, Mark A Doll, et al.
Acta Pharmaceutica Sinica. B|July 29, 2017
Arylamine <i>N</i>-acetyltransferase 2 genotype-dependent <i>N</i>-acetylation of isoniazid in cryopreserved human hepatocytesMark A Doll, Raúl A Salazar-González, Srineil Bodduluri, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 2007
Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variantJason M Walraven, David F Barker, Mark A Doll, et al.
Archives of Toxicology|August 17, 2023
The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposureDavid W Hein, Raúl A Salazar-González, Mark A Doll, et al.
Archives of Toxicology|November 2, 2020
Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypesCarmine S Leggett, Mark A Doll, J Christopher States, et al.
Frontiers in Pharmacology|January 20, 2022
Human Arylamine <i>N</i>-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2Samantha M Carlisle, Patrick J Trainor, Mark A Doll, et al.
Pharmacogenetics|November 27, 2004
The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradationYu Zang, Shuang Zhao, Mark A Doll, et al.
Pageof 12